Atea - International Biopharmaceutical Industry

Current Edition

news

Roche cuts ties with Atea after COVID-19 pill’s trial failure

Roche's seeming lack of confidence in the future of AT-527 appears to be weighing on investors. Atea shares, which soared above $88 in February 2021, dropped 20% to b...

19 November 2021 news Atea | clinical trial

Continue Reading →

news

Atea, Roche change plans for oral COVID-19 drug after trial setback

Atea's fast ascent last year was due to its plan to use a pill originally developed for hepatitis C infections as a treatment for COVID-19. The strategy resonated wit...

22 October 2021 news Atea | Biotech

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Current Edition

Upcoming Events

Advertisement

Roche cuts ties with Atea after COVID-19 pill’s trial failure

Atea, Roche change plans for oral COVID-19 drug after trial setback

International Biopharmaceutical Industry